What is the ticker symbol for Ocugen?

Ocugen trades under the ticker OCGN on NASDAQ.

What sector does Ocugen operate in?

Ocugen is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OCGN in a portfolio?

PortView shows OCGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Ocugen (OCGN) Stock Analysis

NASDAQHealthcareBiotechnology

$1.34+0.38%

1-year price historyRange $1.03 – $2.48

52-week range$1.34

$1.01$2.73

What Ocugen does

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. The company's developmental pipeline features several key candidates: OCU400: An innovative gene therapy designed to reinstate both the function and structural integrity of the retina across a broad spectrum of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis. OCU410: Another gene therapy candidate, currently being developed to address dry age-related macular degeneration (AMD). OCU200: A novel fusion protein, presently undergoing preclinical evaluation for its potential in treating diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen maintains significant strategic collaborations, including a partnership with CanSino Biologics Inc. for the joint development and manufacturing of gene therapies, and an alliance with Bharat Biotech for the commercialization of COVAXIN within the United States market. The company's corporate headquarters are situated in Malvern, Pennsylvania.

Key metrics

Market cap

$452.71M

P/E (TTM)

-5.13

EPS (TTM)

$-0.26

Beta

2.20

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$1.37

200-day avg

$1.51

52-week high

$2.73

52-week low

$1.01

CEO

Shankar Musunuri

ETFs linked to OCGN

Broad-market and Healthcare sector ETFs an investor holding Ocugen is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OCGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OCGN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Ocugen?: Ocugen trades under the ticker OCGN on NASDAQ.
Which exchange is OCGN listed on?: OCGN is listed on NASDAQ.
What sector does Ocugen operate in?: Ocugen is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OCGN in a portfolio?: PortView shows OCGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.